NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Slave1,

I believe the issue is resolved by the wording that exwannabe pointed out in the filings and I believe the reason this is the case is the two products are dealing with different levels of terminal polarization strength with more mature DCs being highly polar so the components likely need to be somewhat different. I also agree with exwannabe that the issue likely is already resolved as the wording in the Q points to just the IND paperwork being reworked to take advantage of new opportunities. Best wishes.